RxDoctor Payments Data

Brittany Sowders, APRN

Nurse Practitioner · Brownsville, KYNPI 1033595947

Payments from drug & device makers

$2,882in general payments, 2019–2025

Across 186 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$593
  • Lilly USA, LLC$423
  • Axsome Therapeutics, Inc.$401
  • Novo Nordisk$168
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$134
  • Corcept Therapeutics$115
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,882100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,882 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,103
Medicare patients
35
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$92,423
Trelegy ElliptaFluticasone/Umeclidin/Vilanter107$70,446
MounjaroTirzepatide46$48,328
FarxigaDapagliflozin Propanediol78$43,843
EliquisApixaban72$40,003
VraylarCariprazine Hcl23$32,588
JanuviaSitagliptin Phosphate51$21,600
TrulicityDulaglutide17$21,440
QuliptaAtogepant16$17,881
JardianceEmpagliflozin25$17,260
VascepaIcosapent Ethyl54$17,149
BrilintaTicagrelor27$15,106
InvokanaCanagliflozin13$11,521
XareltoRivaroxaban15$10,303
AbrysvoRsv Vacc, Pref A And Pref B/Pf27$8,516

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$168$92,42389 claims
GSKTrelegy Ellipta, Shingrix$62$74,427125 claims
Lilly USA, LLCMounjaro, Trulicity$423$69,76863 claims
AstraZenecaFarxiga, Brilinta$36$58,949105 claims
AbbVieVraylar, Qulipta, Linzess, Synthroid$593$58,663103 claims
PfizerEliquis, Abrysvo, Dilantin$19$50,147110 claims
Kowa Pharmaceuticals America, Inc.Livalo$20$3,86512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Brownsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →